Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Crossover Vaccination of Women Previously Randomized Into Protocol 04-C-N191(NCI)/IC-200403(INCIENSA)

NCT01086709 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT01086709
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01086709 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Crossover Vaccination of Women Previously Randomized Into Protocol 04-C-N191(NCI)/IC-200403(INCIENSA)
Lead sponsor
National Cancer Institute (NCI)
Phase
Observational
Overall status
Completed
Start date
January 27, 2010
Completion date
March 17, 2015
Enrollment
5,444 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cervical neoplasia, hpv infections